Literature DB >> 19881947

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry.

R Hamilton1, C Gray, S A Bélanger, A E Warren, R M Gow, S Sanatani, J-M Côté, J Lougheed, J LeBlanc, S Martin, B Miles, C Mitchell, D A Gorman, M Weiss, R Schachar.   

Abstract

Entities:  

Year:  2009        PMID： 19881947      PMCID： PMC2765391     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  33 in total

1.  American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.

Authors: 
Journal:  J Dev Behav Pediatr       Date:  2008-08       Impact factor: 2.225

2.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.

Authors:  Domenico Corrado; Cristina Basso; Andrea Pavei; Pierantonio Michieli; Maurizio Schiavon; Gaetano Thiene
Journal:  JAMA       Date:  2006-10-04       Impact factor: 56.272

3.  Symptoms preceding sudden cardiac death in the young are common but often misinterpreted.

Authors:  Aase Wisten; Torbjörn Messner
Journal:  Scand Cardiovasc J       Date:  2005-07       Impact factor: 1.589

Review 4.  Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Authors:  L S Goldman; M Genel; R J Bezman; P J Slanetz
Journal:  JAMA       Date:  1998-04-08       Impact factor: 56.272

5.  Sudden death in children and adolescents.

Authors:  C Wren; J J O'Sullivan; C Wright
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

6.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease.

Authors:  Amanda J Shillingford; Marianne M Glanzman; Richard F Ittenbach; Robert R Clancy; J William Gaynor; Gil Wernovsky
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

Review 8.  Sudden cardiac death in pediatrics.

Authors:  Yaniv Bar-Cohen; Michael J Silka
Journal:  Curr Opin Pediatr       Date:  2008-10       Impact factor: 2.856

9.  Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Authors:  Victoria L Vetter; Josephine Elia; Christopher Erickson; Stuart Berger; Nathan Blum; Karen Uzark; Catherine L Webb
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

10.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245
View more
  3 in total

Review 1.  A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use.

Authors:  Brendan F Andrade; Darren Courtney; Stephanie Duda; Madison Aitken; Stephanie G Craig; Peter Szatmari; Joanna Henderson; Kathryn Bennett
Journal:  Clin Child Fam Psychol Rev       Date:  2019-12

Review 2.  Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Authors:  Jose Martinez-Raga; Carlos Knecht; Nestor Szerman; María I Martinez
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

3.  MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.

Authors:  Kenoki Ohuchida; Kazuhiro Mizumoto; Tadashi Kayashima; Hayato Fujita; Taiki Moriyama; Takao Ohtsuka; Junji Ueda; Eishi Nagai; Makoto Hashizume; Masao Tanaka
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.